drugset / Trial / NCT04777071

An Investigational Scan (68Ga-PSMA-11 PET) for the Imaging of Prostate Cancer

NCT04777071

Phase 2 Active not recruiting 141 enrolled University of Washington
NaSingle-groupOpen-labelDiagnostic

Summary

This trial studies how well 68Ga-PSMA-11 PET scan works in imaging patients with prostate cancer. Diagnostic procedures, such as 68Ga-PSMA-11 PET may find and diagnose prostate cancer and improve monitoring of treatment response.

Timeline

Start
2021-05-17
Primary completion
2025-07-15
Completion
2030-07-15

Drugs

EvaluationDrugModalityDoseRoute
Subject 68Ga-PSMA-11 Diagnostic / imaging agent Intravenous